Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 12918
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740605(US20250154150, Compound 527)
Affinity DataIC50: 1.20nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740618(US20250154150, Compound 561)
Affinity DataIC50: 1.30nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740617(US20250154150, Compound 528)
Affinity DataIC50: 1.60nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740609(US20250154150, Compound 425)
Affinity DataIC50: 1.90nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740607(US20250154150, Compound 407)
Affinity DataIC50: 2.20nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740612(US20250154150, Compound 487)
Affinity DataIC50: 2.40nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740615(US20250154150, Compound 523)
Affinity DataIC50: 2.40nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740604(US20250154150, Compound 447)
Affinity DataIC50: 2.80nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740611(US20250154150, Compound 486)
Affinity DataIC50: 3.10nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740608(US20250154150, Compound 424)
Affinity DataIC50: 3.70nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740614(US20250154150, Compound 520)
Affinity DataIC50: 4.80nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740616(US20250154150, Compound 526)
Affinity DataIC50: 5.10nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740606(US20250154150, Compound 391)
Affinity DataIC50: 9.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740603(US20250154150, Compound Control)
Affinity DataIC50: 12nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740613(US20250154150, Compound 515)
Affinity DataIC50: 27.7nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Suzhou Yabao Pharmaceutical R&D

US Patent
LigandPNGBDBM740610(US20250154150, Compound 440)
Affinity DataIC50: 36.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent